Amgen to cut 350 staffers following $28B Horizon takeovernews2023-10-24T18:25:47+00:00October 24th, 2023|Endpoints News|
Sanders goes after NIH for granting exclusive patent for potential cancer therapynews2023-10-24T16:58:01+00:00October 24th, 2023|Endpoints News|
Merck KGaA raises awareness for smoldering MS symptoms that cause patients to ‘unravel’news2023-10-24T16:45:17+00:00October 24th, 2023|Endpoints News|
How Novo Nordisk’s Rybelsus went from pandemic washout to blockbuster amid the GLP-1 boomnews2023-10-24T16:41:23+00:00October 24th, 2023|Endpoints News|
MarketingRx roundup: Fishawack rebrands as Avalere Health; BMS, Gilead, Amgen reup clinical diversity programnews2023-10-24T16:11:47+00:00October 24th, 2023|Endpoints News|
Bristol Myers pays $350M upfront for rights to heart drug Camzyos in Asianews2023-10-24T15:04:27+00:00October 24th, 2023|Endpoints News|
BrainStorm to lay off workers; Lilly inks a subcutaneous dealnews2023-10-24T14:51:47+00:00October 24th, 2023|Endpoints News|
A hacker leaked millions of 23andMe users’ data, and the leak of ancestry data could have implications on health infonews2023-10-24T13:23:28+00:00October 24th, 2023|Endpoints News|
OrbiMed raises $4.3B to invest in biotech companies, as well as royalty deals and China startupsnews2023-10-24T12:30:55+00:00October 24th, 2023|Endpoints News|
Immutep reports PhII data of LAG-3 drug plus Keytruda in first-line NSCLCnews2023-10-24T11:21:36+00:00October 24th, 2023|Endpoints News|
